inNOveta Biomedical LLC — Department of Health and Human Services SBIR Phase II: NCEZID-020-PHS2019
inNOveta Biomedical LLC — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $998,399
- Agency
- Department of Health and Human Services · Centers for Disease Control and Prevention
- Program / Phase
- SBIR · Phase II
- Topic
- NCEZID-020-PHS2019
- NAICS
- —
- Place of performance
- GA
- Period
- —
Description
The objective of this potential project is to combine the long-term antibacterial efficacy of a silicone rubber, S-nitrosothiol based nitric oxide (NO) donor in combination with the liquid-infusion of silicone oil to provide an ultra-slippery interface to prevent bacterial and protein adhesion that can be used on indwelling urinary or intravascular catheters to prevent or significantly reduce biofilm formation by organisms known to cause healthcare-associated infections. The overall goal of Phase II is to provide data and specifications necessary to obtain initial 510(k) clearance and initiate clinical use of the NO generating SNAP catheter for reduced thrombosis and infection within one year of the completion of Phase II activities.